Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: A multivariate analysis of results at five years

Clinical Transplantation

Volumn 21, Issue 3, 2007, Pages 330-336

  Legendre, Christophe ^a   Brault, Yves ^b   Morales, José M ^c   Oberbauer, Rainer ^d   Altieri, Paolo ^e   Riad, Hany ^f   Mahony, John ^g   Messina, Maria ^h   Pussell, Bruce ⁱ   Martínez, Javier G ^j   Lelong, Magali ^b   Burke, James T ^b   Neylan, John K F ^k  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Clinical Research and Development   (France)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e San Michele Hospital   (Italy)

^f MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^g ROYAL NORTH SHORE HOSPITAL   (Australia)

^h Azienda Ospedaliera di Torino   (Italy)

ⁱ PRINCE OF WALES HOSPITAL   (Australia)

^j HOSPITAL UNIVERSITARIO LA FE   (Spain)

^k PFIZER INC   (United States)

more..

Author keywords

Cyclosporine withdrawal; Glomerular filtration rate; Multivariate analysis; Sirolimus

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN; STEROID;

ADOLESCENT; ADULT; AGE; AGED; ANALYSIS OF COVARIANCE; ARTICLE; CHILD; CONTROLLED STUDY; CRYOPRESERVATION; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LINEAR REGRESSION ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; REOPERATION; RISK ASSESSMENT; RISK FACTOR; STUDENT T TEST; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CREATININE; CYCLOSPORINE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SIROLIMUS;

EID: 34248167675     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00645.x     Document Type: Article

References (17)

1. Meier-K riesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004: 4: 1284.
2. Hariharan S, Mc Bride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002: 62: 311.
3. Nankivell BJ, Borrows RJ, Fung CLS et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003: 349: 2326.
4. Nankivell BJ, Borrows RJ, Fung CLS et al. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004: 78: 557.
5. Webster AC, L ee VWS, Chapman JR, Craig JC. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: A systemic review and meta-analysis of randomized trials. Transplantation 2006: 81: 1234.
6. Mulay AT, Hussain N, Fergusson D, Knoll GA. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials. Am J Transplant 2005: 5: 1748.
7. Johnson RWG, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 2001: 72: 777.
8. Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995: 59: 1683.
9. Huber P.J. Robust Statistics. New York: John Wiley & Sons, Inc., 1981.
10. Oberbauer R, Segoloni G, Campistol JM et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant Int 2005: 18: 22-28.
11. Kasiske BL, Gaston RS, Gourishaker S et al. Long-term deterioration of kidney allograft function. Am J Transplant 2005: 5: 1405.
12. Stallone G, Di Paolo S, Schena A et al. Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. J Am Soc Nephrol 2004: 15: 228.
13. Boratyńska M, Banasik M, Patrzalek D, Szyber P, Klinger M. Sirolimus delays recovery from post-transplant renal failure in kidney graft recipients. Transplant Proc 2005: 37: 839.
14. Lebranchu Y, Buchler M, Etienne I et al. 12 month results of a randomized trial comparing sirolimus (SRL) versus cyclosporine (CsA) in 150 transplant patients receiving a cadaveric renal graft. Am J Transplant 2005: 5 (Suppl. 11): 540.
15. Diekmann F, Budde K, Oppenheimer F et al. Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction. Am J Transplant 2004: 4: 1869.
16. Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States. N Engl J Med 2000: 342: 605.
17. Halimi JM, Laouad I, Buchler M et al. Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005: 5: 2281.